Argentina Genomics Market Overview, 2030

The start of Argentina's national genomic mapping project marks a significant advancement in the nation's scientific environment and a notable development in its genomics industry. This project paved the way for the creation of a national genomic database, which will facilitate research that is specifically suited to the genetic profile of the Argentine people. The initiative has strengthened Argentina's ability to engage in international genomic collaborations while promoting domestic competence in genomics research. With breakthroughs like the sequencing of the soy genome, Argentina's progress in genomics is centered on its agricultural biotechnology industry, which is a key area of strength. Argentina, one of the top soybean producers worldwide, uses genomics to create genetically modified plants with increased resistance to pests, diseases, and environmental challenges. These advancements have significantly increased the nation's agricultural productivity and international competitiveness. The advancement of genomics is heavily dependent on national research institutions like CONICET National Scientific and Technical Research Council and academic organizations. Progress in both agricultural genomics and human health applications has resulted from cooperative initiatives between universities, research organizations, and new biotechnology firms. With fluctuating research budgets and erratic government financing limiting the long-term planning and implementation of genomics initiatives, economic instability remains a major barrier. The fragmentation of genomic information between healthcare facilities and various research organizations is another ongoing problem. This fragmentation impedes the creation of unified national databases necessary for thorough genomic research, thereby delaying advancements in fields like customized medicine and rare disease identification. Argentina continues to make significant contributions to international genomic research, particularly in areas related to its economy and public health priorities, in spite of these difficulties.

According to the research report, ""Argentina Genomic Market Overview, 2030,"" published by Bonafide Research, the Argentina Genomic market is expected to reach a market size of more than USD 450 Million by 2030. The genomics industry in Argentina is expanding steadily, and the market value is expected to rise at a significant CAGR in the future years. Although Argentina may not yet have the market size of the top genomics economies, its growth is being propelled by its strategic investments in agricultural biotechnology and new personalized medicine programs. In Argentina, the genomics industry is in a position to profit from both local demand and export prospects, particularly in the area of agrigenomics. The main engine behind Argentina's genomics sector is its agriculture industry, particularly the demand from agribusinesses for cutting-edge genomic technologies to boost crop output, pest resistance, and drought tolerance. Considering Argentina is among the top exporters of soybeans, maize, and wheat in the world, the integration of genomics into seed development is regarded as essential for preserving competitiveness in international markets. The introduction of novel genomic seed types, which are specifically tailored to the environmental circumstances of South America, is one of the major changes in Argentina's genomics landscape. By lowering reliance on chemical pesticides and fertilizers, these advancements improve crop productivity while also promoting sustainable agricultural methods. Several small Argentine biotech businesses that focus on genomic research and genetic diagnostics are supported by two key players in the country's genomics sector: INTA National Institute of Agricultural Technology and CONICET. The gap between scientific research and business applications is closed by the cooperation of these organizations. The integration of genomic data into customized medicine, especially in cancer treatments, is a growing trend in Argentina's genomics industry. In Argentina, genomic testing is being used more and more by oncology centers to customize treatments according to individual genetic profiles, which represents a major advancement toward precision healthcare.

The genomics market by product is divided into Products and Services, The majority of the items are bioinformatics tools, consumables, DNA/RNA extraction kits, sequencing kits, and reagents for genomic workflows. These items are necessary for performing genetic studies, such genotyping, targeted gene panels, and whole-genome sequencing. Furthermore, genomic seed varieties and other specialized genomic products are essential to agricultural biotechnology, meeting the demands of Argentina's major agribusiness industry. The top businesses in Argentina's genomics industry are INTA (Instituto Nacional de Tecnología Agropecuaria), CONICET (National Scientific and Technical Research Council), and up-and-coming biotech companies like Bitgenia and Gota Genomics, which offer genetic testing solutions and diagnostic kits. Large international corporations like Thermo Fisher Scientific and Illumina also provide sophisticated genomic platforms and supplies through their distribution presence in Argentina.Bioinformatics tools for data interpretation, the technology that is fueling product demand includes genotyping microarrays, PCR-based assays, and Next-Generation Sequencing (NGS). From oncology diagnostics to agricultural genomics, these technologies have broadened their uses throughout sectors. The applications of these genomic products are found in clinical diagnostics, notably in oncology, rare diseases, and infectious diseases, as well as in drug development, forensic science, and animal breeding programs. These products are primarily used by research institutes, hospitals, universities, and agribusinesses. Argentina offers the following services: genetic counseling, whole-genome and exome sequencing, prenatal testing, and ancestry testing. The top service providers are Mendelics, Gota Genomics, and collaborations between clinical labs and public research institutes. The primary industries that make use of genomic services are veterinary sciences, agriculture, personalized medicine, and epidemiological research. In Argentina, the variety and availability of genomic products and services are anticipated to increase as a result of ongoing cooperation between research institutions and the private sector.

The genomics industry in Argentina employs a variety of the most revolutionary technology in the nation's genomic environment is Next-Generation Sequencing (NGS), which enables the quick, high-throughput analysis of complete genomes, exomes, and specific areas. NGS is extensively utilized in a variety of fields, including clinical diagnostics, particularly in oncology for identifying mutations and informing personalized treatment strategies, and agricultural genomics, where it is used to create genetically enhanced crop types like wheat and soy. In order to aid research and innovation, NGS platforms have been utilized more and more by public organizations like CONICET and INTA, as well as by commercial biotech companies. Despite its widespread use for forensic applications, pathogen identification, genotyping, and gene expression analysis, the polymerase chain reaction (PCR) continues to be a key technology in the genomics industry in Argentina. PCR is a popular instrument in clinical and research contexts due to its versatility, cost, and speed, particularly in agricultural biotechnology and infectious illness diagnostics. The main uses of microarrays are in genomic profiling and gene expression studies, which support applications in agrigenomics and cancer research. Microarrays continue to provide affordable solutions for certain, focused research studies, even if their usage has decreased somewhat with the growth of NGS. The conventional gold standard for sequencing, Sanger sequencing, is still utilized to sequence smaller genomic regions and to confirm NGS findings, notably in the diagnosis of uncommon genetic diseases. Flow cytometry enhances genomic technologies by facilitating cell sorting and biomarker identification, notably in cancer diagnostics and immunology research. Technologies that support Argentina's genomic industry include bioinformatics platforms for analyzing large-scale genomic data and CRISPR-based tools for gene editing. The incorporation of these technologies offers a complete toolbox for researchers and healthcare professionals, fostering progress in Argentina in the fields of agriculture, epidemiology, and personalized medicine. It is expected that the usage of these technologies will increase as genomic literacy increases and infrastructure gets better.

One of the most important areas is diagnostics, especially in oncology, where genomic testing is used to identify mutations in malignancies such as breast and lung cancer. These tests inform the use of targeted treatments, which increases the effectiveness of treatment and improves results for patients. Genomics is increasingly used in cardiology to aid in the diagnosis of genetic cardiac illnesses, such as familial hypercholesterolemia, and in rare disease diagnostics, where it provides essential information about diseases that were previously undiagnosable. enomics aids in the monitoring of infectious illnesses, particularly tuberculosis and Chagas disease, both of which are common in Argentina. By allowing scientists to comprehend the molecular basis of disease processes, genomic technology improves drug discovery and development. Argentine universities and biotechnology firms are becoming more and more cooperative in identifying novel drug targets by utilizing genomic data for pharmacogenomics research, which aims to forecast how patients would respond to particular treatments. Despite the fact that its acceptance is still in its infancy, Precision Medicine is a developing field. With a major emphasis on cancer treatment, genomic insights are aiding in the personalization of medical care according to individual genetic profiles. Government programs and collaborations with research organizations such as CONICET are predicted to hasten the integration of precision medicine into conventional healthcare. Argentina's dominance in agricultural biotechnology is well recognized in the field of Agriculture & Animal Genomics. Genomic research is extensively utilized in crop improvement programs, especially in the development of wheat, maize, and soybean cultivars that are resistant to pests or drought. Livestock genomics is also becoming more popular, notably in cattle breeding for improved milk production and disease resistance. Other applications include forensic genomics, which is utilized in criminal investigations, and population genetics research, which examines the wide range of Argentina's historical heritage. These programs demonstrate Argentina's strategic emphasis on utilizing genomics to enhance public health, bolster its bioeconomy, and increase food security.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Genomic Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product & Services
• Products
• Services

By Technology
• Next-Generation Sequencing (NGS)
• PCR
• Microarrays
• Sanger Sequencing
• Flow Cytometry
• Others

By Application
• Diagnostics (Oncology, Cardiology, Rare Diseases, Infectious Diseases, Others)
• Drug Discovery and Development
• Precision Medicine
• Agriculture & Animal Genomics
• Other Applications Show more